info icon

This is a non-core endpoint: only basic statistics are computed.

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

I9_PHLETHROMBIC

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G08
  • Hospital discharge: ICD-9 3259X
  • Hospital discharge: ICD-8 32100
  • Cause of death: ICD-10 G08
  • Cause of death: ICD-9 3259X
  • Cause of death: ICD-8 32100

2 out of 7 registries used, show all original rules.

11

4. Check minimum number of events

None

11

5. Include endpoints

None

11

6. Filter based on genotype QC (FinnGen only)

11

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G00-G09
Name in latin
Phlebitis/thrombophlebitis intracranialis/intraspinalis

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 206 119 82
Only index persons 149 94 55
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population 38.40 36.55 39.95
Only index persons 31.20 32.03 29.79

-FinnGen-

Key figures

All Female Male
Number of individuals 11 9 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 32.31 29.95 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
9
12.91
3.37
1.3
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
10
11.55
3.19
1.3
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
6
15
7.40
2.45
2.7
2.1
mg/l
42.4
103.3
—
6
9
(3033658) Prothrombin time (PT) actual/Normal
6
18
6.00
2.11
7.7
4.8
%
97.2
96.7
—
6
18
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
11
68
+∞
2.08
16.9
5.9
u/l
63.6
79.9
1.08
11
62
(3023368) Bacteria identified in Blood by Culture
5
12
6.63
2.08
2.4
8.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
18
4.19
1.47
1.6
2.4
mmol/l
0.8
0.9
—
5
18
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
5
19
3.93
1.39
1.2
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
28
0.00
1.18
0.0
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
5
22
3.29
1.18
22.8
6.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
6
29
3.31
1.12
15.3
4.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
23
0.00
0.91
0.0
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
5
27
2.54
0.80
1.8
4.3
g/l
37.2
36.6
—
5
27
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
11
91
+∞
0.68
4.9
3.6
mmol/l
6.2
5.7
0.78
11
85
(40768804) Tissue Pathology biopsy report
6
40
2.09
0.48
1.3
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
6
42
1.93
0.47
16.8
3.9
%
1.0
0.7
—
6
42
(3019069) Monocytes/100 leukocytes in Blood
6
42
1.93
0.47
16.7
4.0
%
8.2
8.0
—
6
42
(3006504) Eosinophils/100 leukocytes in Blood
6
42
1.93
0.47
17.2
3.9
%
1.8
3.2
—
6
42
(3018010) Neutrophils/100 leukocytes in Blood
6
43
1.86
0.46
13.7
3.9
%
50.8
55.4
—
6
43
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
11
95
+∞
0.45
6.1
4.4
mu/l
1.3
1.7
0.79
11
90
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6
44
1.79
0.44
4.7
4.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11
96
+∞
0.44
5.5
3.8
mmol/l
4.4
4.9
1.49
11
91
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
18
0.00
0.44
0.0
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
11
92
+∞
0.44
27.6
9.7
mmol/l
139.8
139.9
0.12
11
87
(3023103) Potassium [Moles/volume] in Serum or Plasma
11
92
+∞
0.44
27.8
9.8
mmol/l
3.9
3.9
0.46
11
87
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5
37
1.64
0.29
3.2
4.4
mmol/l
1.2
1.2
—
5
28
(3019198) Lymphocytes [#/volume] in Blood
6
47
1.60
0.27
15.8
4.1
e9/l
2.1
1.7
—
6
42
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
2.0
—
0.7
—
0
5
(36660697) Celiac disease serology panel - Serum
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3000492) Spirometry study
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
0
12
0.00
0.22
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.22
0.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
5
41
1.40
0.13
1.4
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
41
1.40
0.13
3.2
3.0
—
—
—
0
0
(3015736) pH of Urine
5
44
1.25
0.12
4.2
2.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
11.1
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.2
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
150.6
—
0
5
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
5.7
—
0
6
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
512.6
—
0
7
(3020961) Endomysium IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
3.5
—
4.1
—
0
6
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint I9_PHLETHROMBIC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have I9_PHLETHROMBIC.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: I9_PHLETHROMBIC – IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data